Advanced Cell Technology to Announce Second Quarter Financial Results on Thursday, August 8th

Advanced Cell Technology to Announce Second Quarter Financial Results on Thursday, August 8th

Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that it will release its second quarter financial results for the period ended June 30, 2012 on Thursday, August 8, after the market closes. The company will hold a conference call and webcast to discuss the results and provide a corporate update at 4:30 p.m. eastern time that day.

Interested parties may access the call live by dialing (888) 264-3177 or 706-902-4345 and using conference ID 90962449. This event is also being streamed via webcast. The webcast is available at . A replay of the call will also be available via the same link.

Advanced Cell Technology, Inc., is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit .

Suggested Articles

Loretta Itri, M.D. has been helping Immunomedics out with its troubled antibody-drug conjugate. Now, she’s signing on as its chief medical officer.

Light Chain Bioscience, a unit of Swiss biotech Novimmune, has been handed a nice royalty milestone check from partner Takeda.

The fund received money from Chinese organizations inside and outside the biopharma industry, enabling CICC Capital to ease past its financing goal.